US Edition
9 Articles
9 Articles
Supply problems are related to ‘an increase in sales of insulin cartridges, combined with a limited laboratory production capacity, which does not temporarily meet demand', according to ANSM.
According to the laboratory, tensions are expected until the end of 2025 for its injectable solutions used to treat diabetes in adults, adolescents and children.
On 5 August, the French health authorities reported supply tensions in Europe for two pre-filled insulin cartridges from the Danish Novo Nordisk laboratory. An impact on Luxembourg is expected.
A shortage of insulin due to industrial difficulties L的ANSM points to European supply difficulties concerning two pre-filled cartridges, Fiasp PumpCart and NovoRapid PumpCart (100 U/mL), compatible only with Ypsomed's YpsoPump mylife pump. According to the agency, this is an imbalance between an increase in sales and a temporarily limited production capacity, which no longer allows to meet demand in the state. LANSM states that this situation co…
Two insulin cartridges from the Danish Novo Nordisk laboratory, used by thousands of diabetic patients in France, are threatened with shortages in Europe, the French health authorities said this Tuesday.
French health authorities reported Tuesday that there are supply shortages in Europe for two pre-filled insulin cartridges from the Danish laboratory Novo Nordisk, used by several thousand diabetic patients in France.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
